Form D · Pharmaceuticals
AMBIT BIOSCIENCES CORP
San Diego, CA · CIK 0001131543
Offering snapshot reported Nov 9, 2012 · SEC filing
- Reported sold
- $22.2M Offering amount: $44.8M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 25, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 9, 2012 | Initial | $22,206,064 | No comparison | 16 | SEC filing |
| May 30, 2012 | Initial | $7,066,803 | No comparison | 16 | SEC filing |
| Jul 11, 2011 | Initial | $22,000,006 | No comparison | 20 | SEC filing |
| Oct 15, 2010 | Initial | $14,999,327 | No comparison | 18 | SEC filing |
| Apr 15, 2010 | Initial | $12,000,000 | No comparison | 2 | SEC filing |
| Jul 30, 2009 | Initial | $0 | No comparison | 1 | SEC filing |
| Jun 29, 2009 | Initial | $6,428,542 | No comparison | 13 | SEC filing |
| Nov 13, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 7, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-186740
Source: Form D, filed Nov 9, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David P. Bonita | Director |
| Athena Countouriotis | Executive |
| Steven Elms | Director |
| Standish M. Fleming | Director |
| Alan Fuhrman | Executive |
| Faheem Hasnain | Director |
| Kerry A. Kelly, J.D. | Executive |
| Alan J. Lewis, Ph.D. | Director, Executive |
| Allan Marchington | Director |
| Michael A. Martino | Director, Executive |
| Christopher J. Morl | Executive |
| Isai Peimer | Director |
| Joseph Regan | Director |
| M. Scott Salka | Director, Executive |
| Wendell Wierenga, Ph.D. | Executive |
| Saiid Zarrabian | Director |
| Alexander Zukiwski | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4215 Sorrento Valley Blvd.
San Diego, CA, 92121
San Diego, CA, 92121